skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Serum concentrations of adipokines in psoriasis and cardiometabolic risk

Przegląd dermatologiczny, 2019-01, Vol.106 (1), p.16-24 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0033-2526 ;EISSN: 2084-9893 ;DOI: 10.5114/dr.2019.83441

Full text available

Citations Cited by
  • Title:
    Serum concentrations of adipokines in psoriasis and cardiometabolic risk
  • Author: Pasierb, Anna ; Pietrzak, Radosław ; Rykowski, Paweł ; Bartoszewicz, Zbigniew ; Stakun, Małgorzata ; Rudnicka, Lidia ; Czuwara, Joanna
  • Subjects: adipokines ; Atherosclerosis ; Body mass index ; cardiometabolic risk ; Cardiovascular disease ; Dermatology ; Lipids ; Metabolic syndrome ; Obesity ; Proteins ; Psoriasis ; psoriasis severity ; Systematic review
  • Is Part Of: Przegląd dermatologiczny, 2019-01, Vol.106 (1), p.16-24
  • Description: Introduction Psoriasis is associated with symptoms of the metabolic syndrome. Adipokines are bioactive mediators secreted by adipose tissue. They influence inflammatory reactions, insulin resistance, diabetes and atherosclerosis. Alterations in serum levels of some adipokines have been reported in patients with psoriasis. Objective A cross-sectional study was performed to better understand the role of adipokines in psoriasis, by assessing their levels and relationship with disease severity. Material and methods Serum fasting levels of six different adipokines – adiponectin, leptin, visfatin, resistin, chemerin, and retinol binding protein 4 (RBP4) – were measured in 42 patients with psoriasis and correlated with the Psoriasis Area and Severity Index, body surface area, body mass index, waist-hip ratio and lipid parameters. Results The results showed that adipokines did not correlate with psoriasis severity, with the exception of RBP4 concentration, which showed a statistically significant difference between patients with mild, moderate and severe psoriasis. RBP4 was elevated in moderate and severe psoriasis, what can correspond with the therapeutic effect of retinoids in psoriasis depending on fat tissue capacity. Significant negative correlations was observed between adiponectin/leptin ratio and following parameters: with body mass index (p < 0.0001), waist-hip ratio (p = 0.04) and visceral fat (p = 0.0001) and a correlation with HDL cholesterol (p = 0.0005). A total of 83.3% (35/42) showed an adiponectin/leptin ratio below 0.5, which isindicative of high cardiometabolic risk. Conclusions To the best of our knowledge, this is the first study assessing six different adipokines in sera of patients with psoriasis and their correlation with disease severity and metabolic syndrome components, showing increased cardiovascular risk in patients with psoriasis, based on the adiponectin/leptin ratio.
  • Publisher: Poznan: Termedia Publishing House
  • Language: English;Polish
  • Identifier: ISSN: 0033-2526
    EISSN: 2084-9893
    DOI: 10.5114/dr.2019.83441
  • Source: ProQuest Central
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait